In a true first, the Food and Drug Administration is allowing 23andMe to sell its direct-to-consumer genetic test kits that provide information about an individual’s risk to certain diseases such as Alzheimer’s or Parkinson’s disease.
23andMe’s $199 genetic tests are available with the FDA’s blessing nearly three and a half years after the agency first ordered 23andMe to immediately stop selling...
London-based genomics company DNAFit has launched Elevate, an online training platform that incorporates users’ genetic information to create personalized workout plans.
Elevate, which DNAFit developed with the input of Olympic track and field athlete Greg Rutherford, is based on the company’s saliva-based genetic test kit. It screens for 45 specific gene variants, which may be linked to each...
Toronto-based Newtopia, a personalized health and wellness company, has raised $10 million in Series A funding to expand its offering of health management and coaching plans based on genetic testing and behavioral science. A syndicate of both US and Canadian investors took part in the round, as well as Bloom Burton & Co., which specializes in the health sector through its affiliate Bloom...
